Biogen (BIIB) Tops Q4 EPS by 3c; offers outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $248.93 --0%
Financial Fact:
Diluted earnings per share attributable to Biogen Idec Inc.: 219.4M
Today's EPS Names:
UVV, SII, SCKT, More
Financial Fact:
Diluted earnings per share attributable to Biogen Idec Inc.: 219.4M
Today's EPS Names:
UVV, SII, SCKT, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q4 EPS of $3.44, $0.03 better than the analyst estimate of $3.41. Revenue for the quarter came in at $2.45 billion versus the consensus estimate of $2.41 billion.
GUIDANCE:
Biogen sees FY2025 EPS of $15.25-$16.25, versus the consensus of $16.24.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- People Incorporated (PPLI) PT Lowered to $47 at Citizens - Shares Meaningfully Undervalue Business
- Ashland (ASH) Misses Q4 EPS by 16c ; Offers Guidance
- Lime Energy (LIME) Reports Q3 EPS of $0.63 ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
